Results 121 to 130 of about 5,084 (185)

BTLA-Expressing Memory B Cells Are Associated with Belimumab-Induced Improvement in Systemic Lupus Erythematosus. [PDF]

Int J Mol Sci
Nishi T, Hayakawa K, Ikeda K, Fujishiro M, Kataoka Y, Yamaji K, Takamori K, Tamura N, Sekigawa I, Morimoto S.   +9 more
europepmc   +1 more source

Unexpected Role of B and T Lymphocyte Attenuator in Sustaining Cell Survival during Chronic Allostimulation

Journal of Immunology, 2007
Michelle A. Hurchla, J. Sedy, K. Murphy
semanticscholar   +1 more source

Immune checkpoint imbalance in ANCA-associated vasculitis: insights into disease activity and precision immunotherapy. [PDF]

Front Med (Lausanne)
García-Serrano L, Martinez-Valenzuela L, Draibe J.   +2 more
europepmc   +1 more source

B and T lymphocyte attenuator inhibits LPS-induced endotoxic shock by suppressing Toll-like receptor 4 signaling in innate immune cells

Proceedings of the National Academy of Sciences of the United States of America, 2013
Yoshihisa Kobayashi, A. Iwata, Kotaro Suzuki, A. Suto, Saki Kawashima, Yukari Saito, T. Owada, Midori Kobayashi, N. Watanabe, H. Nakajima   +9 more
semanticscholar   +1 more source

Interleukin-2 transcriptomic expression correlates with prolonged survival and with GNAS alterations in patients with advanced cancers. [PDF]

ESMO Open
Ahmed J, Nishizaki D, Fujiwara Y, DePietro P, Jensen TJ, McFall T, Kato S, Kurzrock R.   +7 more
europepmc   +1 more source

The Search for Predictive Biomarkers in Response to Immune Checkpoint Inhibitors and Associated Adverse Events. [PDF]

J Pers Med
Agostini M, Traldi P, Hamdan M.
europepmc   +1 more source

Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a BTLA Agonist Antibody (Venanprubart) in Healthy Participants, Patients with Systemic Lupus Erythematosus, and Patients with Psoriasis: Results From Three Phase 1 Studies. [PDF]

Clin Pharmacol Drug Dev
Vendel AC, Benichou O, Chang CY, Datta G, Ferrante A, Ghosh I, Moser BA, Sweeney SE, Witcher J, Linnik MD.   +9 more
europepmc   +1 more source

Synergistic immunomodulatory combinations induce robust human tolerogenic dendritic cells for antigen-specific regulatory T cell generation. [PDF]

J Pharmacol Exp Ther
Jia S, Mell J, Deak P.
europepmc   +1 more source

400 自己免疫疾患におけるB and T lymphocyte attenuator(BTLA)の遺伝子多型(膠原病と類縁疾患(6), 第55回日本アレルギー学会秋季学術大会)

Japanese Journal of Allergology, 2005
openaire   +1 more source

Multiplex profiling of 16 immune checkpoints identifies novel serum biomarker panels for breast cancer detection and TNBC stratification: A case-control study. [PDF]

PLoS One
Stayoussef M, Habel A, Xu W, Bessaad M, Bouaziz H, Ayadi M, Almawi WY, Larbi A, Yacoubi-Loueslati B.   +8 more
europepmc   +1 more source